- Home
- XPRO vs QDEL Comparison
XPRO vs QDEL Comparison
Compare XPRO & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XPRO | QDEL |
|---|---|---|
| Founded | 1938 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2013 | 2022 |
Fundamental Metrics
Financial Performance| Metric | XPRO | QDEL |
|---|---|---|
| Price | $18.31 | $21.29 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $14.00 | ★ $32.75 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.45 | N/A |
| Revenue | $522,493,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.62 |
| Revenue Next Year | $1.72 | $4.07 |
| P/E Ratio | $39.53 | ★ N/A |
| Revenue Growth | ★ 14.89 | N/A |
| 52 Week Low | $6.70 | $19.50 |
| 52 Week High | $18.38 | $42.21 |
Technical Indicators
Market Signals| Indicator | XPRO | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 27.91 |
| Support Level | $12.18 | $19.50 |
| Resistance Level | N/A | $31.19 |
| Average True Range (ATR) | 0.96 | 1.81 |
| MACD | 0.12 | -0.62 |
| Stochastic Oscillator | 85.39 | 2.57 |
Price Performance
Historical ComparisonAbout XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.